{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:21:34Z","timestamp":1789410094446,"version":"build-2803163510"},"reference-count":38,"publisher":"Norwegian Medical Association","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2009,8,27]]},"DOI":"10.4045\/tidsskr.09.35501","type":"journal-article","created":{"date-parts":[[2009,8,31]],"date-time":"2009-08-31T09:56:18Z","timestamp":1251712578000},"page":"1631-4","source":"Crossref","is-referenced-by-count":4,"title":["Myosittspesifikke autoantistoffer"],"prefix":"10.4045","volume":"129","author":[{"given":"Jan Tore","family":"Gran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd Cecilie","family":"Dobloug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Taraldsrud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Bohan A, Peters JB. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255\u2009\u2013\u200986.","DOI":"10.1097\/00005792-197707000-00001"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Duncan AG, Richardson JB, Klein JB et al. Clinical, serologic and immunogenetic studies in patients with dermatomyositis. Acta Derm Venereol 1990; 71: 312\u2009\u2013\u20096.","DOI":"10.2340\/0001555571312316"},{"key":"ref=3","unstructured":"Baron M, Small P. Polymyositis\/dermatomyositis: clinical features and outcome in 22 patients. J\u00a0Rheumatol 1985; 12: 283\u2009\u2013\u20096."},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Hengstman GJD. Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected. Curr Rheumatol Rep 2007; 9: 280\u2009\u2013\u20095.","DOI":"10.1007\/s11926-007-0045-7"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyosits\/dermatomyositis and related conditions. Nihon Rinsho Meneki Gakkai Kaishi 2007; 30: 444\u2009\u2013\u200954.","DOI":"10.2177\/jsci.30.444"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Hausmanova-Petrusewicz I, Kowalska-Oledzka E, Miller FW et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997; 40: 1257\u2009\u2013\u200966.","DOI":"10.1002\/art.1780400710"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Hengstman GJD, Brenk L, Vree Egberts WTM et al. High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders. J Neurol 2005; 252: 534\u2009\u2013\u20097.","DOI":"10.1007\/s00415-005-0683-5"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Brouwer R, Hengstman GJD, Egberts WV et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116\u2009\u2013\u200923.","DOI":"10.1136\/ard.60.2.116"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Mimori T, Imura Y, Kakashima R et al. Autoantibodies in idiopathic inflammatory myopathy; an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007; 19: 523\u2009\u2013\u20099.","DOI":"10.1097\/BOR.0b013e3282f01a8c"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Rheum Rep 2000; 12: 475\u2009\u2013\u200981.","DOI":"10.1097\/00002281-200011000-00001"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Gelpi C, Kanterewicz E, Gratacos J et al. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996; 39: 692\u2009\u2013\u20097.","DOI":"10.1002\/art.1780390424"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep 2006; 8: 196\u2009\u2013\u2009203.","DOI":"10.1007\/s11926-996-0025-3"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Hengstman GJD, van Engelen BGM, Vree Egberts WTM et al. Myositis-specific autoantibodies: overview and recent developments. Curr Opin Rheum 2001; 13: 476\u2009\u2013\u200982.","DOI":"10.1097\/00002281-200111000-00004"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Selva-O\u2019Callaghan A, Labrador-Horrillo M, Solans-Laque R et al. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 2006; 55: 791\u2009\u2013\u20099.","DOI":"10.1002\/art.22237"},{"key":"ref=15","unstructured":"Gran JT. Antisyntetasesyndrom. Tidsskr Nor L\u00e6geforen 2002; 122: 2270-2."},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Yoshifuji H, Fujii T, Kobayashi S. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with inflammatory myopathies. Autoimmunity 2006; 39; 233\u2009\u2013\u200941.","DOI":"10.1080\/08916930600622884"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Suda T, Fujisawa T, Enomoto N et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 2006; 28: 1005\u2009\u2013\u200912.","DOI":"10.1183\/09031936.06.00038806"},{"key":"ref=18","unstructured":"Kotani T, Makino S, Takeuchi T et al. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose monitoring improves the prognosis of acute\/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 2008; 35: 254\u2009\u2013\u20099."},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Takada K, Kishi J, Miyasaka N. Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis\/polymyositis: a retrospective study. Mod Rheumatol 2007; 17: 123\u2009\u2013\u200930.","DOI":"10.1007\/s10165-007-0553-3"},{"key":"ref=20","unstructured":"Nawata Y, Kurasawa K, Takabayashi K et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999; 26: 1527\u2009\u2013\u200933."},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Nagasaka K, Harigai M, Tateishi M et al. Efficacy of combination treatment with cyclosporine A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol 2003; 13: 231\u2009\u2013\u20098.","DOI":"10.3109\/s10165-003-0205-1"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Ochi S, Nanki T, Takada T et al. Favourable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis. Clin Exp Rheumatol 2005; 23: 707\u2009\u2013\u200910.23. Christopher-Stine L, Plotz PH. Myositis: an update on pathogenesis. Curr Opin Rheum 2004; 16: 700\u2009\u2013\u20096.","DOI":"10.1097\/01.bor.0000141925.21941.d8"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Chinoy H, Fertig N, Oddis CV et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007; 66: 1345\u2009\u2013\u20099.","DOI":"10.1136\/ard.2006.068502"},{"key":"ref=24","unstructured":"Legault D, McDermott J, Crous-Tsanaclis AM et al. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol 2008; 35: 169\u2009\u2013\u200971."},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Miller T, Al-Lozi MT, Lopate G et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 2002; 73: 420\u2009\u2013\u20098.","DOI":"10.1136\/jnnp.73.4.420"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Kao AH, Lacomis D, Lucas M et al. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004; 50: 209\u2009\u2013\u200915.","DOI":"10.1002\/art.11484"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Hengstman GI, Brouwer R, Egberts WT. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002; 249: 69\u2009\u2013\u200975.","DOI":"10.1007\/PL00007850"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"el-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol 2002; 46: 560\u2009\u2013\u20095.","DOI":"10.1067\/mjd.2002.120620"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Klein RQ, Teal V, Taylor L et al. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol 2007; 57: 937\u2009\u2013\u200943.","DOI":"10.1016\/j.jaad.2007.08.024"},{"key":"ref=30","unstructured":"Zhang ZL, Lai AY, Xu D et al. Clinical analysis of 29 patients with clinically amyopathic dermatomyositis. Zhonghua Yi Xue Za Zhi 2007; 87: 1345\u2009\u2013\u20097."},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinct subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002; 46: 626\u2009\u2013\u200936.","DOI":"10.1067\/mjd.2002.120621"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Sato S, Hirakata M, Kuwana M. Autoantibodies to a\u00a0140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571\u2009\u2013\u20096.","DOI":"10.1002\/art.21023"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Hengstman GJD. Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: Not as simple as suspected. Curr Rheumatol Rep 2007; 9: 280\u2009\u2013\u20095.","DOI":"10.1007\/s11926-007-0045-7"},{"key":"ref=34","unstructured":"Toyoshima M, Sato A, Chida K et al. Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35: 281\u2009\u2013\u20097."},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Miyazaki E, Ando M, Muramatsu T et al. Early assessment of rapidly progressing interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol 2007; 26: 436\u2009\u2013\u20099.","DOI":"10.1007\/s10067-005-0147-4"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Targoff IN, Mamyrova G, Trieu EP. A novel antibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 2006; 54: 3682\u2009\u2013\u20099.","DOI":"10.1002\/art.22164"},{"key":"ref=37","unstructured":"Targoff IN, Trieu EP, Levy-Neto M. Autoantibodies to transcriptional intermediary factor- 1 gamma in dermatomyositis. Abstrakt. Arthritis Rheum 2006; 54 (suppl): 518."},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Peng JC, Sheen TS, Hsu MM. Nasopharyngeal carcinoma with dermatomyositis. Arch Otolaryngol Head Neck Surg 1995; 121: 1298\u2009\u2013\u20091301.","DOI":"10.1001\/archotol.1995.01890110072013"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:02:49Z","timestamp":1781672569000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2009\/08\/oversiktsartikkel\/myosittspesifikke-autoantistoffer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,27]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2009,8,27]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.35501","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,27]]}}}